Enhancer Detail

Comprehensive information about experimentally validated enhancers

About Enhancer
Enhancer ID: E_01570
Species: Homo sapiens
Position : chr3:15768491-15768703
Year: 2025
Title: Enhancer Extrachromosomal Circular DNA ANKRD28 Elicits Drug Resistance via POU2F2-Mediated Transcriptional Network in Multiple Myeloma
Genome Build: hg38
Enhancer Type: Enhancer
Condition: Disease
Disease Name: multiple myeloma
PMID:  40167268
MONDO: MONDO:0005178
Tissue: Blood
Tissue Ontology ID: UBERON:0000178
Cell Source: Multiple myeloma cells
CVCL ID:
Cell Type: plasma cell
Cell Ontology ID: CL:0000945
Experiment Type: Enhancer activity assay
High Throughput Method: ATAC-seq, ChIP-seq, CUT&Tag
Low Throughput Method: CRISPR knockout, CRISPRi, ChIP-RT-qPCR, FISH
About Target Gene
Target gene : JUNB
About TF
TF name : POU2F2
About Regulatory State
Regulatory State : Active
Upstream Pathway Annotation of TF
GeneName Pathway Name Source Gene Number
POU2F2 BCR signaling pathway pid 70
POU2F2 RNA polymerase II transcribes snRNA genes reactome 70
POU2F2 Validated transcriptional targets of deltaNp63 isoforms pid 47
Enhancer Associated Network
Overlapping Enhancers (hg38) 4 found
Enhancer ID Position Tissue Cell Disease
E_01571 chr3:15768491-15768703 Blood plasma cell multiple myeloma
E_01572 chr3:15768491-15768703 Blood plasma cell multiple myeloma
E_01573 chr3:15768491-15768703 Blood plasma cell multiple myeloma
E_01842 chr3:15768491-15768703 Bone Marrow hematopoietic stem and progenitor cell --
Expression of Target Genes for the Enhancer